A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Skin Cancer · Cutaneous Squamous Cell Carcinoma (CSCC) · Actinic Keratosis (AK) · Organ Transplant Recipient

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UPMC Falk Dermatology, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Marissa Lobl, MD, PhD) · loblm@upmc.edu · 412-647-4200
Contact: Study coordinator (Melissa Pugliano-Mauro, MD)
UPMC St Margarets Dermatology, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Marissa Lobl, MD, PhD) · loblm@upmc.edu · (412) 784-7350
Melissa Pugliano-Mauro, MD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Advanced Solid Tumor · Metastatic Solid Tumor · Refractory Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Sarasota, United States · Boston, United States

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Adjustment Disorder · Adjustment Disorder With Anxious Mood · Cancer

Abroad (travel likely)RecruitingPHASE2

Abbotsford, Australia · Northcote, Australia

The Florida ASCENT Study

Cancer · Food Deprivation · Food Habits

Abroad (travel likely)Recruiting

Gainesville, United States

Personalised Immunotherapy Platform

Melanoma · Cutaneous Squamous Cell Carcinoma · Basal Cell Carcinoma

Abroad (travel likely)Recruiting

Sydney, Australia · Sydney, Australia